Early-onset lichenoid graft-vs.-host disease: a unique variant of acute graft-vs.-host disease occurring in peripheral blood stem cell transplant recipients

被引:1
|
作者
Magro, Cynthia M. [1 ]
Kerns, Mary Jo [2 ]
Votava, Henry [3 ]
Vasil, Katherine E. [4 ]
Dyrsen, Molly E. [1 ]
Morrison, Carl D. [5 ]
机构
[1] Cornell Univ, Weill Med Coll, New York, NY 10065 USA
[2] Univ Cincinnati, Dept Dermatol Cincinnatti, Cincinnati, OH 45221 USA
[3] NYU, Med Ctr, Div Dermatopathol, New York, NY 10016 USA
[4] Riverside Methodist Hosp, Columbus, OH 43214 USA
[5] Roswell Pk Canc Inst, Buffalo, NY USA
关键词
BONE-MARROW-TRANSPLANTATION; TOXIC EPIDERMAL NECROLYSIS; INCLUSION-BODY CHANGE; PATHOPHYSIOLOGY; MANIFESTATIONS; DIFFERENTIATE; MANAGEMENT; SPECTRUM; LESIONS; INJURY;
D O I
10.1111/j.1600-0560.2009.01427.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: A complication of stem cell transplantation is chronic graft-vs.-host disease (GvHD), developing months to years after transplant; the two commonest manifestations are lichenoid GvHD and scleroderma. The purpose of this study was to characterize early-onset lichenoid GvHD. Methods: A retrospective study identified patients diagnosed with early-onset lichenoid GvHD. This diagnosis was correlated with type of transplant and concurrent or prior episodes of acute GvHD. Results: Patients in whom a sex mismatch was present between donor and recipient were included, representing a study population of 17. All received an allogeneic peripheral blood stem cell transplant (PBSCT). All patients had biopsy proven lichenoid GvHD within 60 days or less following transplantation. All had concurrent gastrointestinal symptoms which was biopsy proven GvHD in thirteen of the cases. FISH XY studies revealed that the infiltrating lymphocytes were of donor origin in 12 of the cases, mixed in three and of host origin in two cases. Conclusions: Early-onset lichenoid GvHD is exclusive to the PBSCT setting and appears to be mediated by donor lymphocytes, reflecting the higher numbers of donor T cells encountered in PBSCT. We consider this reaction pattern a distinctive subtype of acute GvHD.
引用
收藏
页码:549 / 558
页数:10
相关论文
共 50 条
  • [31] National Institutes of Health-Defined Chronic Graft-vs.-Host Disease in Pediatric Hematopoietic Stem Cell Transplantation Patients Correlates With Parameters of Long-Term Immune Reconstitution
    Lawitschka, Anita
    Gueclue, Ece Dila
    Januszko, Angela
    Koermoeczi, Ulrike
    Rottal, Arno
    Fritsch, Gerhard
    Bauer, Dorothea
    Peters, Christina
    Greinix, Hildegard T.
    Pickl, Winfried F.
    Kuzmina, Zoya
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [32] Early Endothelial Activation in a Mouse Model of Graft vs Host Disease Following Chemotherapy
    Pereira, Melrine
    Lee, Natasha Ting
    Noonan, Jonathan
    Willcox, Abbey E. H.
    Calvello, Ilaria
    Georgy, Smitha Rose
    Selan, Carly
    Chia, Joanne S.
    Hauw, Wayne
    Wang, Xiaowei
    Peter, Karlheinz
    Robson, Simon C.
    Nandurkar, Harshal H.
    Sashindranath, Maithili
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [33] Donor cell reaction to OKT3 as predictor of chronic graft-vs-host disease in hematopoietic stem cell recipients
    Lindemann, Monika
    Ottinger, Hellmut D.
    Elmaagacli, Ahmet H.
    Trenschel, Rudolf
    Rebmann, Vera
    Beelen, Dietrich W.
    Grosse-Wilde, Hans
    EXPERIMENTAL HEMATOLOGY, 2006, 34 (12) : 1753 - 1758
  • [34] Graft-vs-Host Disease Following Allogeneic Hematopoietic Cell Transplantation
    Pidala, Joseph
    CANCER CONTROL, 2011, 18 (04) : 268 - 276
  • [35] Occurrence of autoantibodies in chronic graft vs. host disease after allogeneic stem cell transplantation
    Wechalekar, A
    Cranfield, T
    Sinclair, D
    Ganzckowski, M
    CLINICAL AND LABORATORY HAEMATOLOGY, 2005, 27 (04): : 247 - 249
  • [36] Spontaneous graft versus host disease occurring in a patient with multiple myeloma after autologous stem cell transplant
    Fidler, Christian
    Klumpp, Thomas
    Mangan, Kenneth
    Martin, MaryEllen
    Sharma, Manish
    Emmons, Robert
    Lu, Meina
    Kropf, Patricia
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (02) : 219 - 221
  • [37] Mycophenolate mofetil for the management of steroid-refractory acute graft vs host disease
    Pidala, J.
    Kim, J.
    Perkins, J.
    Field, T.
    Fernandez, H.
    Perez, L.
    Ayala, E.
    Kharfan-Dabaja, M.
    Anasetti, C.
    BONE MARROW TRANSPLANTATION, 2010, 45 (05) : 919 - 924
  • [38] Adiponectin and resistin in acute and chronic graft-vs-host disease patients undergoing allogeneic hematopoietic stem cell transplantation
    Robak, Oliver
    Kuzmina, Zoya
    Winkler, Andreas
    Kalhs, Peter
    Rabitsch, Werner
    Greinix, Hildegard
    CROATIAN MEDICAL JOURNAL, 2016, 57 (03) : 255 - 265
  • [39] Liver Graft-Versus-Host Disease is associated with poor survival among allogeneic hematopoietic stem cell transplant recipients
    Modi, Dipenkumar
    Ye, Jing Christine
    Surapaneni, Malini
    Singh, Vijendra
    Chen, Wei
    Jang, Hyejeong
    Deol, Abhinav
    Ayash, Lois
    Alavi, Asif
    Ratanatharathorn, Voravit
    Uberti, Joseph P.
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (10) : 1072 - 1080
  • [40] SEVERE HYPERCHOLESTEROLEMIA IN PATIENTS WITH GRAFT-VS-HOST DISEASE AFFECTING THE LIVER AFTER STEM CELL TRANSPLANTATION
    Joukhadar, Rene
    Chiu, Ken
    ENDOCRINE PRACTICE, 2012, 18 (01) : 90 - 97